Bain Capital Life Sciences Investors, Llc Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

DRNA Quotes by TradingView

Bain Capital Life Sciences Investors, LLC Transaction History

Date Transaction Value Shares Traded Form
Nov 19 2019
SELL
Open market or private sale
$38,552,501 $22.03 p/Share
1,750,000
May 29 2019
SELL
Open market or private sale
$20,000,000 $12.5 p/Share
1,600,000
Dec 18 2017
BUY
Exercise of conversion of derivative security
-
8,454,388
Dec 18 2017
BUY
Open market or private purchase
$1,995,000 $7.0 p/Share
285,000
Dec 18 2017
BUY
Grant, award, or other acquisition
-
190,849

Also insider at

MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
REPL
Replimune Group, Inc. Healthcare
> 10% Shareholder
SWTX
SpringWorks Therapeutics, Inc. Healthcare
> 10% Shareholder
ARQT
Arcutis Biotherapeutics, Inc. Healthcare
> 10% Shareholder
ANNX
Annexon, Inc. Healthcare
> 10% Shareholder
APTX
Aptinyx Inc. Healthcare
> 10% Shareholder
RPID
RAPID MICRO BIOSYSTEMS, INC. Healthcare
> 10% Shareholder
XLO
Xilio Therapeutics, Inc. Healthcare
> 10% Shareholder
SLDB
Solid Biosciences Inc. Healthcare
KYTX
Kyverna Therapeutics, Inc.
NAMS
NewAmsterdam Pharma Co N.V.
BCL

Bain Capital Life Sciences Investors, LLC

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on DRNA

Follow Dicerna Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

News

Receive news related to Dicerna Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DRNA